173 related articles for article (PubMed ID: 12859967)
21. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H
J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787
[TBL] [Abstract][Full Text] [Related]
22. S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells.
Hsieh HL; Schäfer BW; Weigle B; Heizmann CW
Biochem Biophys Res Commun; 2004 Apr; 316(3):949-59. PubMed ID: 15033494
[TBL] [Abstract][Full Text] [Related]
23. The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins.
Yatime L; Betzer C; Jensen RK; Mortensen S; Jensen PH; Andersen GR
Structure; 2016 Dec; 24(12):2043-2052. PubMed ID: 27818100
[TBL] [Abstract][Full Text] [Related]
24. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches.
Xie J; Burz DS; He W; Bronstein IB; Lednev I; Shekhtman A
J Biol Chem; 2007 Feb; 282(6):4218-31. PubMed ID: 17158877
[TBL] [Abstract][Full Text] [Related]
25. Receptor for advanced glycation end products (RAGE) functions as receptor for specific sulfated glycosaminoglycans, and anti-RAGE antibody or sulfated glycosaminoglycans delivered in vivo inhibit pulmonary metastasis of tumor cells.
Mizumoto S; Takahashi J; Sugahara K
J Biol Chem; 2012 Jun; 287(23):18985-94. PubMed ID: 22493510
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
Mahajan N; Bahl A; Dhawan V
Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
[TBL] [Abstract][Full Text] [Related]
27. Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function.
Moroz OV; Burkitt W; Wittkowski H; He W; Ianoul A; Novitskaya V; Xie J; Polyakova O; Lednev IK; Shekhtman A; Derrick PJ; Bjoerk P; Foell D; Bronstein IB
BMC Biochem; 2009 Apr; 10():11. PubMed ID: 19386136
[TBL] [Abstract][Full Text] [Related]
28. Expression, purification and fluorine-18 radiolabeling of recombinant S100 proteins--potential probes for molecular imaging of receptor for advanced glycation endproducts (RAGE) in vivo.
Hoppmann S; Haase C; Richter S; Pietzsch J
Protein Expr Purif; 2008 Feb; 57(2):143-52. PubMed ID: 18039581
[TBL] [Abstract][Full Text] [Related]
29. Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis.
Loeser RF; Yammani RR; Carlson CS; Chen H; Cole A; Im HJ; Bursch LS; Yan SD
Arthritis Rheum; 2005 Aug; 52(8):2376-85. PubMed ID: 16052547
[TBL] [Abstract][Full Text] [Related]
30. Expression of members of the S100 Ca2+-binding protein family in guinea-pig smooth muscle.
Daub B; Schroeter M; Pfitzer G; Ganitkevich V
Cell Calcium; 2003 Jan; 33(1):1-10. PubMed ID: 12526882
[TBL] [Abstract][Full Text] [Related]
31. Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B.
Curran CS; Bertics PJ
Int Immunol; 2011 Dec; 23(12):713-28. PubMed ID: 22025532
[TBL] [Abstract][Full Text] [Related]
32. Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes.
Tsoporis JN; Hatziagelaki E; Gupta S; Izhar S; Salpeas V; Tsiavou A; Rigopoulos AG; Triantafyllis AS; Marshall JC; Parker TG; Rizos IK
Molecules; 2020 Nov; 25(22):. PubMed ID: 33182705
[TBL] [Abstract][Full Text] [Related]
33. Tissue mRNA for S100A4, S100A6, S100A8, S100A9, S100A11 and S100P Proteins in Colorectal Neoplasia: A Pilot Study.
Peterova E; Bures J; Moravkova P; Kohoutova D
Molecules; 2021 Jan; 26(2):. PubMed ID: 33466593
[TBL] [Abstract][Full Text] [Related]
34. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules.
Roth J; Vogl T; Sorg C; Sunderkötter C
Trends Immunol; 2003 Apr; 24(4):155-8. PubMed ID: 12697438
[TBL] [Abstract][Full Text] [Related]
35. S100 family signaling network and related proteins in pancreatic cancer (Review).
Ji YF; Huang H; Jiang F; Ni RZ; Xiao MB
Int J Mol Med; 2014 Apr; 33(4):769-76. PubMed ID: 24481067
[TBL] [Abstract][Full Text] [Related]
36. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of S100A6 and matrix metalloproteinase 9, but not S100A2, S100A4, and S100A7, is associated with epidermal carcinogenesis.
Zhu L; Kohda F; Nakahara T; Chiba T; Tsuji G; Hachisuka J; Ito T; Tu Y; Moroi Y; Uchi H; Furue M
J Dermatol Sci; 2013 Dec; 72(3):311-9. PubMed ID: 23993025
[TBL] [Abstract][Full Text] [Related]
38. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells.
Reddy MA; Li SL; Sahar S; Kim YS; Xu ZG; Lanting L; Natarajan R
J Biol Chem; 2006 May; 281(19):13685-13693. PubMed ID: 16551628
[TBL] [Abstract][Full Text] [Related]
39. Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products.
Shanmugam N; Reddy MA; Natarajan R
J Biol Chem; 2008 Dec; 283(52):36221-33. PubMed ID: 18854308
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
